Kyung Kim is a Neurology physician. ClinicalTrials.gov lists 35 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3663 W 6th St
Suite 201
Los Angeles, CA 900203049
Telephone
213-389-0100Registry record last updated 8 Jul 2007.
Clinical trials
- Basic Income Guaranteed: Los Angeles Economic Assistance Pilot
Sponsor: University of Pennsylvania
- Drug Response Testing and Repurposing Using Glioblastoma Organoid
Sponsor: Chungnam National University Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Eisai Inc.Program year20256 payments
- Aimmune Therapeutics, Inc.Program year20252 payments
- Lilly USA, LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
35.9%Corticosteroid35.6%Triamcinolone acetonide83%Methylprednisolone acetate15%Triamcinolone Acetonide2%Part D + Part B<11 patientsAzole Antifungal0.3%Clotrimazole-Betamethasone100%Part D<11 patientsSensory organs
25.3%Corticosteroid25.3%Dexamethasone sodium phosphate100%Part B, office-administered≥133 patientsNervous system
24%Benzodiazepine4.6%Clonazepam51%Alprazolam32%Triazolam9%Lorazepam9%Part D<11 patientsOpioid Agonist2.8%Tramadol Hcl77%Oxycodone Hcl23%Part D<11 patients+ 13 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2007–2017 per NIH RePORTER. The latest:
- Cardiomyocyte Apoptosis and Cardioprotective Actions of Estrogen
University of California-Irvine
FY2017$386,250R01HL111180 - Cardiomyocyte Apoptosis and Cardioprotective Actions of Estrogen
University of California-Irvine
FY2016$386,250R01HL111180 - Cardiomyocyte Apoptosis and Cardioprotective Actions of Estrogen
University of California-Irvine
FY2015$380,456R01HL111180
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”